West Pharmaceutical Services (NYSE:WST) Announces Earnings Results

West Pharmaceutical Services (NYSE:WST) issued its quarterly earnings results on Thursday. The medical instruments supplier reported $0.79 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.08, Briefing.com reports. West Pharmaceutical Services had a net margin of 12.94% and a return on equity of 16.93%. The company had revenue of $456.10 million during the quarter, compared to the consensus estimate of $450.03 million. During the same period in the prior year, the company earned $0.76 EPS. West Pharmaceutical Services’s revenue was up 5.6% on a year-over-year basis. West Pharmaceutical Services updated its FY19 guidance to $3.10-3.15 EPS.

NYSE WST traded down $0.31 on Thursday, reaching $138.86. The company’s stock had a trading volume of 716,036 shares, compared to its average volume of 355,324. West Pharmaceutical Services has a twelve month low of $91.75 and a twelve month high of $152.10. The company has a debt-to-equity ratio of 0.18, a quick ratio of 2.27 and a current ratio of 3.02. The stock has a market cap of $10.24 billion, a PE ratio of 49.42, a PEG ratio of 3.24 and a beta of 1.28. The firm’s 50 day moving average is $142.62 and its two-hundred day moving average is $129.73.

A number of equities research analysts have weighed in on WST shares. Bank of America raised shares of West Pharmaceutical Services from an “underperform” rating to a “neutral” rating in a report on Friday, July 26th. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $158.00 price target for the company in a report on Saturday, August 3rd. Finally, ValuEngine downgraded shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Three analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $130.72.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Featured Story: What is the significance of a dead cat bounce?

Earnings History for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.